![Amanda Hayward](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Amanda Hayward
Chairman at Hoba Therapeutics ApS
Amanda Hayward active positions
Companies | Position | Start | End |
---|---|---|---|
Hoba Therapeutics ApS
![]() Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark. | Chairman | - | - |
Career history of Amanda Hayward
Former positions of Amanda Hayward
Companies | Position | Start | End |
---|---|---|---|
Scheer & Co., Inc.
![]() Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Private Equity Analyst | 2010-05-24 | 2010-05-24 |
Private Equity Investor | 2010-05-24 | 2015-01-09 | |
Connecticut Innovations, Inc.
![]() Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Private Equity Investor | - | - |
Renetx Bio, Inc.
![]() Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Director of Finance/CFO | - | - |
Optherion, Inc.
![]() Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Corporate Officer/Principal | 2011-07-05 | - |
Training of Amanda Hayward
Texas Tech University | Doctorate Degree |
The University of Sheffield | Undergraduate Degree |
Statistics
International
United States | 6 |
United Kingdom | 2 |
Denmark | 2 |
Operational
Private Equity Investor | 2 |
Private Equity Analyst | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 4 |
Finance | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Connecticut Innovations, Inc.
![]() Connecticut Innovations, Inc. Investment ManagersFinance Connecticut Innovations, Inc (CI) is venture capital firm founded in 1989. The firm is headquartered in Rocky Hill, Connecticut. | Finance |
Optherion, Inc.
![]() Optherion, Inc. Medical SpecialtiesHealth Technology Optherion, Inc. develops therapeutic products. It develops products to diagnose and treat dry and wet Age-related Macular Degeneration and other chronic diseases involving the alternative complement system. The company was founded by Gregory S. Hageman, David I. Scheer and Sandy Gordon in 2005 and is headquartered in New Haven, CT. | Health Technology |
Renetx Bio, Inc.
![]() Renetx Bio, Inc. BiotechnologyHealth Technology Renetx Bio, Inc. operates as a biotechnology company that develops disease modifying therapeutics. It offers Nogo Receptor and Cellular Prion Protein technology. The company was founded by Sylvia McBrinn and Stephen Strittmatter in 2009 and is headquartered in New Haven, CT. | Health Technology |
Scheer & Co., Inc.
![]() Scheer & Co., Inc. Investment ManagersFinance Scheer & Co., Inc. ( Scheer ) is a venture capital firm. The firm is founded in 1981 by David I. Scheer. The firm is headquartered in Connecticut, United States. | Finance |
Hoba Therapeutics ApS
![]() Hoba Therapeutics ApS BiotechnologyHealth Technology Hoba Therapeutics ApS engages in research and experimental development in biotechnology. The firm’s purpose is commercialization of pharmaceuticals and biotechnology services. The company was founded on November 28, 2016 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Stock Market
- Insiders
- Amanda Hayward
- Experience